New insights into MS treatment
New insights into MS treatment
Data from two Novartis phase III clinical trials show that adding brain shrinkage (brain volume loss) to an existing tool to assess multiple sclerosis activity (m-Rio) will give a more precise prediction of the likelihood of future disability progression.... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 3 Replies
- 1048 Views
-
Last post by jimmylegs
-
- 5 Replies
- 2211 Views
-
Last post by Jaded
-
- 0 Replies
- 3872 Views
-
Last post by NHE
-
- 0 Replies
- 8713 Views
-
Last post by NHE
-
- 0 Replies
- 2296 Views
-
Last post by NHE
-
- 0 Replies
- 2084 Views
-
Last post by Cece
-
- 0 Replies
- 1826 Views
-
Last post by frodo
-
- 2 Replies
- 994 Views
-
Last post by NHE